Skip Navigation

JNCI Journal of the National Cancer Institute 1999 91(24):2072-2073; doi:10.1093/jnci/91.24.2072
© 1999 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Vastag, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vastag, B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 91, No. 24, 2072-2073, December 15, 1999
© 1999 Oxford University Press

NEWS

Shining Light on Breast Tumors

Brian Vastag

By using near-infrared light, which lies just outside the visible spectrum, researchers may soon be able to map the "optical signature" of breast tissue as a way of distinguishing between benign and malignant tumors. Although not yet ready for the clinic, optical mammography is being tested by several research groups and could obviate the need for biopsy in many women whose mammograms reveal suspicious lesions.

The new technology depends on the amount of blood hemoglobin present to detect a signature difference between benign and malignant tumors. If that difference is significant — still a big "if" — then optical mammography . . . [Full Text of this Article]

Varied Applications

Still Lab-Bound

"Very Preliminary"


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?